Literature DB >> 15280406

Node retrieval in axillary lymph node dissections: recommendations for minimum numbers to be confident about node negative status.

J E A Somner1, J M J Dixon, J S J Thomas.   

Abstract

AIMS: To determine the minimum number of lymph nodes needed in an axillary lymph node dissection (ALND) specimen to be confident that the axilla is free from metastases.
METHODS: The Edinburgh Breast Unit selects patients with large and high grade tumours for ALND; 609 consecutive ALNDs performed between October 1999 and December 2002 were reviewed. Full data about the underlying invasive breast cancer were available for 520 patients. Data were collected regarding number of positive nodes and total number of nodes collected, tumour size and grade, and presence of lymphovascular invasion.
RESULTS: Axillary node metastases were seen in 64% of patients. The mean number of positive nodes found was 3.56, with a mean of 17.9 nodes collected. The highest proportion of patients with lymph node metastases were in the group with 16-20 nodes recovered/specimen (68%); specimens with >20 nodes recovered did not have a higher rate of nodal involvement. There was a significant difference between the proportion of metastasis positive specimens in those with 1-15 nodes recovered (58.5%) and those with 16 or more recovered (69.1%). A linear association test showed a direct correlation between the number of nodes collected and presence of node metastasis (p = 0.0005).
CONCLUSIONS: Although there is no minimum number of nodes that should be recovered in an ALND specimen, 16 nodes should be regarded as a target to ensure a high level of confidence that the nodes are negative. Node positivity in an ALND specimen appears to obey the law of diminishing returns.

Entities:  

Mesh:

Year:  2004        PMID: 15280406      PMCID: PMC1770384          DOI: 10.1136/jcp.2003.015560

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  22 in total

1.  Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities.

Authors:  Neal S Goldstein
Journal:  Am J Surg Pathol       Date:  2002-02       Impact factor: 6.394

2.  Meeting highlights: international consensus panel on the treatment of primary breast cancer.

Authors:  A Goldhirsch; W C Wood; H J Senn; J H Glick; R D Gelber
Journal:  J Natl Cancer Inst       Date:  1995-10-04       Impact factor: 13.506

3.  Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases.

Authors:  C L Carter; C Allen; D E Henson
Journal:  Cancer       Date:  1989-01-01       Impact factor: 6.860

4.  Decreased axillary lymph node retrieval in patients after neoadjuvant chemotherapy.

Authors:  Muna M Baslaim; Osama A Al Malik; Saif S Al-Sobhi; Ezzeldin Ibrahim; Adnan Ezzat; Dahish Ajarim; Asma Tulbah; Mohammad A Chaudhary; Ralph A Sorbris
Journal:  Am J Surg       Date:  2002-10       Impact factor: 2.565

5.  Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined.

Authors:  Fabio Cianchi; Annarita Palomba; Vieri Boddi; Luca Messerini; Filippo Pucciani; Giuliano Perigli; Paolo Bechi; Camillo Cortesini
Journal:  World J Surg       Date:  2002-01-15       Impact factor: 3.352

6.  Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06. 10-year pathologic and clinical prognostic discriminants.

Authors:  E R Fisher; S Anderson; C Redmond; B Fisher
Journal:  Cancer       Date:  1993-04-15       Impact factor: 6.860

7.  Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index.

Authors:  D E Henson; L Ries; L S Freedman; M Carriaga
Journal:  Cancer       Date:  1991-11-15       Impact factor: 6.860

8.  Arm problems and psychological distress after surgery for breast cancer.

Authors:  E Maunsell; J Brisson; L Deschênes
Journal:  Can J Surg       Date:  1993-08       Impact factor: 2.089

9.  Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer.

Authors:  B C H van der Wal; R M J M Butzelaar; S van der Meij; M A Boermeester
Journal:  Eur J Surg Oncol       Date:  2002-08       Impact factor: 4.424

10.  Lymph node harvests directly influence the staging of colorectal cancer: evidence from a regional audit.

Authors:  D F H Pheby; D F Levine; R W Pitcher; N A Shepherd
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

View more
  15 in total

1.  Lymph node ratio is more valuable than level III involvement for prediction of outcome in node-positive breast carcinoma patients.

Authors:  Emin Yildirim; Ugur Berberoglu
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

2.  Lymph node yield and lymph node density for elective level II-IV neck dissections in laryngeal squamous cell carcinoma patients.

Authors:  Melih Cayonu; Evrim Unsal Tuna; Aydın Acar; Ayse Secil Kayalı Dinc; Muammer Melih Sahin; Suleyman Boynuegri; Adil Eryilmaz
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-17       Impact factor: 2.503

3.  Number of negative lymph nodes should be considered for incorporation into staging for breast cancer.

Authors:  San-Gang Wu; Yan Wang; Juan Zhou; Jia-Yuan Sun; Feng-Yan Li; Huan-Xin Lin; Zhen-Yu He
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

4.  Two possible mechanisms of epithelial to mesenchymal transition in invasive ductal breast cancer.

Authors:  Sylvie Dubois-Marshall; Jeremy S Thomas; Dana Faratian; David J Harrison; Elad Katz
Journal:  Clin Exp Metastasis       Date:  2011-07-26       Impact factor: 5.150

Review 5.  Prognostic factors in elderly patients with breast cancer.

Authors:  Alessandro Cappellani; Maria Di Vita; Antonio Zanghì; Andrea Cavallaro; Gaetano Piccolo; Marcello Majorana; Giuseppina Barbera; Massimiliano Berretta
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

6.  Number of negative lymph nodes is associated with disease-free survival in patients with breast cancer.

Authors:  San-Gang Wu; Jia-Yuan Sun; Juan Zhou; Feng-Yan Li; Qin Lin; Huan-Xin Lin; Xun-Xing Guan; Zhen-Yu He
Journal:  BMC Cancer       Date:  2015-02-07       Impact factor: 4.430

7.  Neoadjuvant chemotherapy in breast cancer significantly reduces number of yielded lymph nodes by axillary dissection.

Authors:  Thalia Erbes; Marzenna Orlowska-Volk; Axel Zur Hausen; Gerta Rücker; Sebastian Mayer; Matthias Voigt; Juliane Farthmann; Severine Iborra; Marc Hirschfeld; Philipp T Meyer; Gerald Gitsch; Elmar Stickeler
Journal:  BMC Cancer       Date:  2014-01-03       Impact factor: 4.430

8.  Number of negative lymph nodes can predict survival after postmastectomy radiotherapy according to different breast cancer subtypes.

Authors:  San-Gang Wu; Fang Peng; Juan Zhou; Jia-Yuan Sun; Feng-Yan Li; Qin Lin; Huan-Xin Lin; Yong Bao; Zhen-Yu He
Journal:  J Cancer       Date:  2015-01-20       Impact factor: 4.207

9.  Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy.

Authors:  San-Gang Wu; Jia-Yuan Sun; Juan Zhou; Feng-Yan Li; Hao Zhou; Qin Lin; Huan-Xin Lin; Yong Bao; Zhen-Yu He
Journal:  Radiat Oncol       Date:  2014-12-16       Impact factor: 3.481

10.  Should all breast cancer patients with four or more positive lymph nodes who underwent modified radical mastectomy be treated with postoperative radiotherapy? A population-based study.

Authors:  Haiyong Wang; Li Kong; Chenyue Zhang; Dawei Chen; Hui Zhu; Jinming Yu
Journal:  Oncotarget       Date:  2016-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.